FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
HK$1.86
+0.0100 (+0.541%)
At Close: May 31, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About SinoMab Bioscience Ltd

SinoMab Bioscience Ltd SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunologic... 3681.HK Profile

Golden Star

Ticker Date Change Price
OXM May 29 3.64% $106.80
UTZ May 29 2.43% $18.10
DVAX May 29 3.99% $11.53
GNTX May 28 1.66% $34.43
OHI May 20 4.76% $30.86
CNI May 16 0.600% $126.57
TTWO May 16 9.78% $146.08
RL May 15 11.92% $166.98
LNG May 14 0.235% $157.42
VCLT May 14 0.277% $75.73
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT